FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964699275> ?p ?o ?g. }

• W1964699275 endingPage "1565" @default.
• W1964699275 startingPage "1560" @default.
• W1964699275 abstract "Interleukin-3 (IL-3) is a hematopoietic growth factor that supports the growth of early hematopoietic progenitors in vitro. In vivo administration of recombinant human interleukin-3 (rhIL-3) to normal primates results in a modest and delayed leukocytosis secondary to increases in neutrophils, basophils, and eosinophils. We postulated that the effects of rhIL-3 might be more pronounced in hematologically stressed primates, and therefore administered rhIL-3 to primates after intensive myelosuppressive therapy. Primates received either cyclophosphamide (CPM) at 60 mg/kg or 5-fluorouracil (5-FU) at 75 mg/kg i.v. on two consecutive days. Subsequently, rhIL-3 was administered intravenously or subcutaneously at 20 micrograms/kg per d for 14 d. Compared to controls, all rhIL-3 treated primates experienced higher absolute neutrophil count (ANC) nadirs and dramatic decreases in the period of severe neutropenia (ANC less than 500) after myelosuppressive therapy. RhIL-3 administration resulted in a significant basophilia and eosinophilia, which resolved after discontinuation of the drug. RhIL-3 did not enhance erythroid recovery. Platelet recovery was earlier in rhIL-3-treated animals. However, variations in the platelet recovery observed in control animals, precluded accurate estimation of this effect or its significance. Our results indicate that the administration of rhIL-3 following intensive myelosuppressive therapy dramatically enhances myeloid recovery and ablates the predicted period of prolonged severe neutropenia." @default.
• W1964699275 created "2016-06-24" @default.
• W1964699275 creator A5011776125 @default.
• W1964699275 creator A5018590586 @default.
• W1964699275 creator A5027095419 @default.
• W1964699275 creator A5033550793 @default.
• W1964699275 creator A5034640156 @default.
• W1964699275 creator A5058476408 @default.
• W1964699275 creator A5073625002 @default.
• W1964699275 date "1990-05-01" @default.
• W1964699275 modified "2023-09-23" @default.
• W1964699275 title "Effects of interleukin-3 on hematopoietic recovery after 5-fluorouracil or cyclophosphamide treatment of cynomolgus primates." @default.
• W1964699275 cites W1542735558 @default.
• W1964699275 cites W1549719455 @default.
• W1964699275 cites W1572293017 @default.
• W1964699275 cites W1590406613 @default.
• W1964699275 cites W185149003 @default.
• W1964699275 cites W1984324451 @default.
• W1964699275 cites W2040968837 @default.
• W1964699275 cites W2046188084 @default.
• W1964699275 cites W2050149613 @default.
• W1964699275 cites W2068382284 @default.
• W1964699275 cites W2071595697 @default.
• W1964699275 cites W2149886995 @default.
• W1964699275 cites W2161315957 @default.
• W1964699275 cites W2271842838 @default.
• W1964699275 cites W2281313768 @default.
• W1964699275 cites W2337463302 @default.
• W1964699275 cites W2401982764 @default.
• W1964699275 cites W2408176001 @default.
• W1964699275 doi "https://doi.org/10.1172/jci114605" @default.
• W1964699275 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/296606" @default.
• W1964699275 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2332507" @default.
• W1964699275 hasPublicationYear "1990" @default.
• W1964699275 type Work @default.
• W1964699275 sameAs 1964699275 @default.
• W1964699275 citedByCount "53" @default.
• W1964699275 countsByYear W19646992752013 @default.
• W1964699275 countsByYear W19646992752018 @default.
• W1964699275 countsByYear W19646992752021 @default.
• W1964699275 crossrefType "journal-article" @default.
• W1964699275 hasAuthorship W1964699275A5011776125 @default.
• W1964699275 hasAuthorship W1964699275A5018590586 @default.
• W1964699275 hasAuthorship W1964699275A5027095419 @default.
• W1964699275 hasAuthorship W1964699275A5033550793 @default.
• W1964699275 hasAuthorship W1964699275A5034640156 @default.
• W1964699275 hasAuthorship W1964699275A5058476408 @default.
• W1964699275 hasAuthorship W1964699275A5073625002 @default.
• W1964699275 hasBestOaLocation W19646992751 @default.
• W1964699275 hasConcept C109159458 @default.
• W1964699275 hasConcept C126322002 @default.
• W1964699275 hasConcept C203014093 @default.
• W1964699275 hasConcept C2776694085 @default.
• W1964699275 hasConcept C2776755627 @default.
• W1964699275 hasConcept C2777063308 @default.
• W1964699275 hasConcept C2777129736 @default.
• W1964699275 hasConcept C2777767877 @default.
• W1964699275 hasConcept C2778690821 @default.
• W1964699275 hasConcept C2778923028 @default.
• W1964699275 hasConcept C2779282312 @default.
• W1964699275 hasConcept C2779958370 @default.
• W1964699275 hasConcept C28328180 @default.
• W1964699275 hasConcept C54355233 @default.
• W1964699275 hasConcept C71924100 @default.
• W1964699275 hasConcept C74172505 @default.
• W1964699275 hasConcept C86803240 @default.
• W1964699275 hasConcept C91219811 @default.
• W1964699275 hasConcept C95862172 @default.
• W1964699275 hasConcept C98274493 @default.
• W1964699275 hasConceptScore W1964699275C109159458 @default.
• W1964699275 hasConceptScore W1964699275C126322002 @default.
• W1964699275 hasConceptScore W1964699275C203014093 @default.
• W1964699275 hasConceptScore W1964699275C2776694085 @default.
• W1964699275 hasConceptScore W1964699275C2776755627 @default.
• W1964699275 hasConceptScore W1964699275C2777063308 @default.
• W1964699275 hasConceptScore W1964699275C2777129736 @default.
• W1964699275 hasConceptScore W1964699275C2777767877 @default.
• W1964699275 hasConceptScore W1964699275C2778690821 @default.
• W1964699275 hasConceptScore W1964699275C2778923028 @default.
• W1964699275 hasConceptScore W1964699275C2779282312 @default.
• W1964699275 hasConceptScore W1964699275C2779958370 @default.
• W1964699275 hasConceptScore W1964699275C28328180 @default.
• W1964699275 hasConceptScore W1964699275C54355233 @default.
• W1964699275 hasConceptScore W1964699275C71924100 @default.
• W1964699275 hasConceptScore W1964699275C74172505 @default.
• W1964699275 hasConceptScore W1964699275C86803240 @default.
• W1964699275 hasConceptScore W1964699275C91219811 @default.
• W1964699275 hasConceptScore W1964699275C95862172 @default.
• W1964699275 hasConceptScore W1964699275C98274493 @default.
• W1964699275 hasIssue "5" @default.
• W1964699275 hasLocation W19646992751 @default.
• W1964699275 hasLocation W19646992752 @default.
• W1964699275 hasLocation W19646992753 @default.
• W1964699275 hasLocation W19646992754 @default.
• W1964699275 hasLocation W19646992755 @default.
• W1964699275 hasOpenAccess W1964699275 @default.
• W1964699275 hasPrimaryLocation W19646992751 @default.
• W1964699275 hasRelatedWork W1964699275 @default.

• next